Related references
Note: Only part of the references are listed.Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
Karl G. Csaky et al.
OPHTHALMOLOGY (2015)
Genomic aspects of age-related macular degeneration
Kuniko Horie-Inoue et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
One-year outcome of ranibizumab for neovascular age-related macular degeneration: a thorough analysis in a real-world clinical setting
Andrea Gabai et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2014)
Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration Results from a 12-Month Randomized Phase 2 Study: AURORA Study
Xiaoxin Li et al.
OPHTHALMOLOGY (2014)
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
Juan E. Grunwald et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
Age-related macular degeneration and changes in the extracellular matrix
Wanda Romaniuk
MEDICAL SCIENCE MONITOR (2014)
Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema
Mark Humayun et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2014)
One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study
Juan-Carlos Gutiérrez-Hernández et al.
Translational Vision Science & Technology (2014)
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review
Paolo Lanzetta et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Anti-angiogenic effect of KH902 on retinal neovascularization
Fei Wang et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Bevacizumab and Triamcinolone Acetonide for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Antivascular Endothelial Growth Factors
Daniele Veritti et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
KH902, a Recombinant Human VEGF Receptor Fusion Protein, Reduced the Level of Placental Growth Factor in Alkali Burn Induced-Corneal Neovascularization
Ai-Yi Zhou et al.
OPHTHALMIC RESEARCH (2013)
Emerging Therapies for Neovascular Age-Related Macular Degeneration Drugs in the Pipeline
Peter K. Kaiser
OPHTHALMOLOGY (2013)
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Brandon G. Busbee et al.
OPHTHALMOLOGY (2013)
The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration
Rufino Silva et al.
OPHTHALMOLOGY (2013)
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Soraya Rofagha et al.
OPHTHALMOLOGY (2013)
EFFECTS OF VEGF INHIBITION ON RETINAL MORPHOLOGY, NEOVASCULAR NETWORK SIZE, AND VISUAL ACUITY IN PATIENTS WITH VASCULARIZED PIGMENT EPITHELIUM DETACHMENT BECAUSE OF OCCULT CHOROIDAL NEOVASCULARIZATION
Daniele Veritti et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Aflibercept in wet AMD: specific role and optimal use
F. Semeraro et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Therapies for Neovascular Age-Related Macular Degeneration: Current Approaches and Pharmacologic Agents in Development
Mostafa Hanout et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Yan Xia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Pharmacokinetics of a long-lasting anti-VEGF fusion protein in rabbit
Hong Li et al.
EXPERIMENTAL EYE RESEARCH (2012)
Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex
Imran Bhutto et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Kang Zhang et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Mechanisms of Age-Related Macular Degeneration
Jayakrishna Ambati et al.
NEURON (2012)
Neovascular Age-Related Macular Degeneration
Daniele Veritti et al.
OPHTHALMOLOGICA (2012)
HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Michael A. Singer et al.
OPHTHALMOLOGY (2012)
Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY (2012)
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
Christine Schmucker et al.
PLOS ONE (2012)
Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)
Quan Dong Nguyen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy
Joao Rafael de Oliveira Dias et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration
Roger A. Sabbadini
BRITISH JOURNAL OF PHARMACOLOGY (2011)
DARPins and other repeat protein scaffolds: advances in engineering and applications
Ykelien L. Boersma et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Preclinical Safety Evaluation of AAV2-sFLT01-A Gene Therapy for Age-related Macular Degeneration
Timothy K. MacLachlan et al.
MOLECULAR THERAPY (2011)
Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule
Michael Lukason et al.
MOLECULAR THERAPY (2011)
A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration
Ming Zhang et al.
OPHTHALMOLOGY (2011)
Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2011)
Age-related macular degeneration: current treatment and future options
Tanya Moutray et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2011)
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
P. Mitchell et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Konstantin Gaengel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown et al.
OPHTHALMOLOGY (2009)
The Pharmacology Study of a New Recombinant Human VEGF Receptor-Fc Fusion Protein on Experimental Choroidal Neovascularization
Ming Zhang et al.
PHARMACEUTICAL RESEARCH (2009)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
DARPins: A new generation of protein therapeutics
Michael T. Stumpp et al.
DRUG DISCOVERY TODAY (2008)
Neovascular age-related macular degeneration - Potential therapies
Aimee V. Chappelow et al.
DRUGS (2008)
Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
Guru Sonpavde et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration
Anne E. Fung et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration
P. K. Kaiser
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Genetic markers and biomarkers for age-related macular degeneration
Robert J. Ross et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2007)
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: Results of a phase I clinical trial
PA Campochiaro et al.
HUMAN GENE THERAPY (2006)
Complement factor H variant increases the risk of age-related macular degeneration
JL Haines et al.
SCIENCE (2005)
The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway
MN Corradetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Development of gene-specific double-stranded RNA drugs
S Barik
ANNALS OF MEDICINE (2004)
High-affinity binders selected from designed ankyrin repeat protein libraries
HK Binz et al.
NATURE BIOTECHNOLOGY (2004)
Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor
SK Selvaraj et al.
BLOOD (2003)
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization
JM Rakic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Effect of squalamine on iris neovascularization in monkeys
M Genaidy et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2002)
Effects of angiogenic growth factor combinations on retinal endothelial cells
R Castellon et al.
EXPERIMENTAL EYE RESEARCH (2002)
Age-related macular degeneration - Epidemiology and optimal treatment
M la Cour et al.
DRUGS & AGING (2002)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
Share Paper
